Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial

Autor: Reinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, Lucas V A Boersma, Juergen Kuschyk, Mikhael F El-Chami, Hendrik Bonnemeier, Elijah R Behr, Tom F Brouwer, Stefan Kaab, Suneet Mittal, Anne-Floor B E Quast, Willeke van der Stuijt, Lonneke Smeding, Jolien A de Veld, Jan G P Tijssen, Nick R Bijsterveld, Sergio Richter, Marc A Brouwer, Joris R de Groot, Kirsten M Kooiman, Pier D Lambiase, Petr Neuzil, Kevin Vernooy, Marco Alings, Timothy R Betts, Frank A L E Bracke, Martin C Burke, Jonas S S G de Jong, David J Wright, Ward P J Jansen, Zachary I Whinnett, Peter Nordbeck, Michael Knaut, Berit T Philbert, Jurren M van Opstal, Alexandru B Chicos, Cornelis P Allaart, Alida E Borger van der Burg, Jose M Dizon, Marc A Miller, Dmitry Nemirovsky, Ralf Surber, Gaurav A Upadhyay, Raul Weiss, Anouk de Weger, Arthur A M Wilde, Louise R A Olde Nordkamp

Publikováno v: European heart journal, 43(47), 4872-4883. Oxford University Press
European Heart Journal, 43, 4872-4883
European Heart Journal, 43(47), 4872-4883. Oxford University Press
Knops, R E, Pepplinkhuizen, S, Delnoy, P P H M, Boersma, L V A, Kuschyk, J, El-Chami, M F, Bonnemeier, H, Behr, E R, Brouwer, T F, Kaab, S, Mittal, S, Quast, A-F B E, van der Stuijt, W, Smeding, L, de Veld, J A, Tijssen, J G P, Bijsterveld, N R, Richter, S, Brouwer, M A, de Groot, J R, Kooiman, K M, Lambiase, P D, Neuzil, P, Vernooy, K, Alings, M, Betts, T R, Bracke, F A L E, Burke, M C, de Jong, J S S G, Wright, D J, Jansen, W P J, Whinnett, Z I, Nordbeck, P, Knaut, M, Philbert, B T, van Opstal, J M, Chicos, A B, Allaart, C P, Borger van der Burg, A E, Dizon, J M, Miller, M A, Nemirovsky, D, Surber, R, Upadhyay, G A, Weiss, R, de Weger, A, Wilde, A A M & Olde Nordkamp, L R A 2022, ' Device-related complications in subcutaneous versus transvenous ICD : a secondary analysis of the PRAETORIAN trial ', European Heart Journal, vol. 43, no. 47, pp. 4872-4883 . https://doi.org/10.1093/eurheartj/ehac496, https://doi.org/10.1093/eurheartj/ehac496
European Heart Journal, 43, 47, pp. 4872-4883

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD (TV-ICD) therapy. The PRAETORIAN trial demonstrated that the S-ICD is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e757a40a17c07ec6eba44a3463f1765a
https://pure.amc.nl/en/publications/devicerelated-complications-in-subcutaneous-versus-transvenous-icd(6df2d41e-5aad-4930-8f10-615ecb7136ac).html

[The implantable cardiac defibrillator: indications and complications]

Autor: T A Tim, Simmers, Frank A L E, Bracke

Publikováno v: Nederlands tijdschrift voor geneeskunde. 157(47)

The implantation of an implantable cardiac defibrillator (ICD) is indicated as a secondary prevention measure for sudden cardiac death in patients surviving a life-threatening ventricular arrhythmia that had no reversible or treatable cause. An ICD i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6e26887ed762234cf83281f0c5fa341
https://pubmed.ncbi.nlm.nih.gov/24252404